A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial
Eleanor Hudson(University of Leeds), Ane Appelt(University of Leeds), Debra Howard(Mount Vernon Cancer Centre), Carole Burnett(St James's University Hospital), M. Hawkins(University College Hospital), Simon Gollins(Velindre Cancer Centre), Samantha Noutch(University of Leeds), Mark Saunders(Manchester Academic Health Science Centre), Alexandra Gilbert(St James's University Hospital), Nicholas P. West(Johannes Gutenberg University Mainz), Jenny F. Seligmann(University of Leeds), David Sebag‐Montefiore(University of Leeds), Ravi Adapala(Wrexham Maelor Hospital), Simon P. Bach(University of Birmingham), Sarah Brown(University of Leeds), Rohit Kochhar(Creative Commons), Alwyn Burrage, Monica Jefford(The Patients Association), Mark Teo(St James's University Hospital), Amanda Webster(Mount Vernon Cancer Centre), Alexandra Smith(University of Leeds), Edward Webb(University of Leeds)
Cited by 14
Related Papers
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640
Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
|Journal of Clinical Oncology|2008|597